These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20824444)

  • 1. Population-based surveillance for rare congenital and inherited disorders: models and challenges.
    Jackson JM; Crider KS; Olney RS
    Adv Exp Med Biol; 2010; 686():133-50. PubMed ID: 20824444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public Health Practice of Population-Based Birth Defects Surveillance Programs in the United States.
    Mai CT; Kirby RS; Correa A; Rosenberg D; Petros M; Fagen MC
    J Public Health Manag Pract; 2016; 22(3):E1-8. PubMed ID: 25905668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited metabolic rare disease.
    Pampols T
    Adv Exp Med Biol; 2010; 686():397-431. PubMed ID: 20824458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital discharge data: can it serve as the sole source of case ascertainment for population-based birth defects surveillance programs?
    Wang Y; Cross PK; Druschel CM
    J Public Health Manag Pract; 2010; 16(3):245-51. PubMed ID: 20357611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and progress of the National Congenital Anomaly and Rare Disease Registration Service.
    Stevens S; Miller N; Rashbass J
    Arch Dis Child; 2018 Mar; 103(3):215-217. PubMed ID: 29066522
    [No Abstract]   [Full Text] [Related]  

  • 6. Birth defects surveillance, epidemiology, and public health.
    Kirby RS; Collins JS
    Birth Defects Res A Clin Mol Teratol; 2011 Dec; 91(12):985. PubMed ID: 22125267
    [No Abstract]   [Full Text] [Related]  

  • 7. National rates of birth defects among hospitalized newborns.
    Bird TM; Hobbs CA; Cleves MA; Tilford JM; Robbins JM
    Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):762-9. PubMed ID: 17063529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening for critical congenital heart disease: essential public health roles for birth defects monitoring programs.
    Olney RS; Botto LD
    Birth Defects Res A Clin Mol Teratol; 2012 Dec; 94(12):965-9. PubMed ID: 23184496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved national prevalence estimates for 18 selected major birth defects--United States, 1999-2001.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Jan; 54(51):1301-5. PubMed ID: 16397457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population perspective on birth defects: from surveillance to epidemiology to public health.
    Kirby RS; Feldkamp M
    Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):745-6. PubMed ID: 17094133
    [No Abstract]   [Full Text] [Related]  

  • 11. EUROCAT: 25 years of European surveillance of congenital anomalies.
    Dolk H
    Arch Dis Child Fetal Neonatal Ed; 2005 Sep; 90(5):F355-8. PubMed ID: 16113149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards a gold standard for national prevalence estimates of birth defects.
    Meyer RE; Sever LE
    Birth Defects Res A Clin Mol Teratol; 2006 Nov; 76(11):770-1. PubMed ID: 17094132
    [No Abstract]   [Full Text] [Related]  

  • 13. Newborn screening for critical congenital heart disease: potential roles of birth defects surveillance programs--United States, 2010-2011.
    Centers for Disease Control and Prevention
    MMWR Morb Mortal Wkly Rep; 2012 Oct; 61(42):849-53. PubMed ID: 23095953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From cause to care: Triple surveillance for better outcomes in birth defects and rare diseases.
    Botto LD; Mastroiacovo P
    Eur J Med Genet; 2018 Sep; 61(9):551-555. PubMed ID: 29902591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impacts of national surveillance for uncommon conditions in childhood.
    Zurynski YA; Peadon E; Bower C; Elliott EJ
    J Paediatr Child Health; 2007 Nov; 43(11):724-31. PubMed ID: 17924937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. State birth defects surveillance programs directory.
    National Center on Birth Defects and Developmental Disabilities, CDC
    Teratology; 2002; 66 Suppl 1():S59-128. PubMed ID: 12239746
    [No Abstract]   [Full Text] [Related]  

  • 17. Selected birth defects data from population-based birth defects surveillance programs in the United States, 2003-2007.
    Birth Defects Res A Clin Mol Teratol; 2010 Dec; 88(12):1062-174. PubMed ID: 21157887
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the Birth Defects Monitoring Program, 1982-1985.
    Lynberg MC; Chavez GF; Edmonds LD; Mulinare J
    Teratology; 1993 Dec; 48(6):650-7. PubMed ID: 8115974
    [No Abstract]   [Full Text] [Related]  

  • 19. Collection, use, and protection of population-based birth defects surveillance data in the united states.
    Mai CT; Law DJ; Mason CA; McDowell BD; Meyer RE; Musa D;
    Birth Defects Res A Clin Mol Teratol; 2007 Dec; 79(12):811-4. PubMed ID: 18064713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDC National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors--United States, 2005-2013.
    Johnson NB; Hayes LD; Brown K; Hoo EC; Ethier KA;
    MMWR Suppl; 2014 Oct; 63(4):3-27. PubMed ID: 25356673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.